14.83
+0.05
+(0.34%)
At close: January 10 at 4:00:02 PM EST
14.83
0.00
(0.00%)
After hours: January 10 at 5:18:10 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 15 | 12 | 15 | 15 |
| Avg. Estimate | 0.03 | -0 | 0.13 | 0.17 |
| Low Estimate | 0.02 | -0.04 | 0.12 | -0.05 |
| High Estimate | 0.04 | 0.05 | 0.17 | 0.32 |
| Year Ago EPS | 0.04 | -0.01 | -0.27 | 0.13 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 14 | 11 | 15 | 15 |
| Avg. Estimate | 212.84M | 211.89M | 840.07M | 879.72M |
| Low Estimate | 210.7M | 207.4M | 837.7M | 850M |
| High Estimate | 214.7M | 216.62M | 843.11M | 896.85M |
| Year Ago Sales | 196.6M | 202.2M | 753.2M | 840.07M |
| Sales Growth (year/est) | 8.26% | 4.79% | 11.53% | 4.72% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | 0.01 | -0.11 | -0.01 | 0.02 |
| EPS Actual | 0.04 | -0.01 | 0.05 | 0.06 |
| Difference | 0.03 | 0.1 | 0.06 | 0.04 |
| Surprise % | 214.22% | 91.06% | 561.68% | 211.04% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.03 | -0 | 0.13 | 0.09 |
| 7 Days Ago | 0.03 | 0 | 0.13 | 0.17 |
| 30 Days Ago | 0.03 | 0 | 0.13 | 0.17 |
| 60 Days Ago | 0.03 | 0.02 | 0.13 | 0.2 |
| 90 Days Ago | 0.03 | 0.05 | 0.1 | 0.28 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 2 | 1 | 14 | 1 |
| Down Last 7 Days | -- | 1 | -- | 1 |
| Down Last 30 Days | 6 | 3 | -- | 6 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MYGN | -32.50% | 64.50% | 149.63% | 24.57% |
| S&P 500 | 8.59% | 11.42% | 13.98% | 13.43% |
Upgrades & Downgrades
| Maintains | B of A Securities: Underperform to Underperform | 12/13/2024 |
| Initiated | UBS: Neutral | 12/10/2024 |
| Downgrade | Leerink Partners: Outperform to Market Perform | 12/9/2024 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 11/18/2024 |
| Maintains | Piper Sandler: Neutral to Neutral | 11/11/2024 |
| Initiated | Morgan Stanley: Equal-Weight | 9/19/2024 |
Related Tickers
QGEN Qiagen N.V.
44.68
-1.28%
GRAL GRAIL, Inc.
17.73
+0.40%
SHC Sotera Health Company
13.11
-2.09%
MTD Mettler-Toledo International Inc.
1,210.99
-2.85%
DGX Quest Diagnostics Incorporated
151.79
-1.45%
WAT Waters Corporation
380.35
+1.64%
RVTY Revvity, Inc.
113.88
-2.18%
NEOG Neogen Corporation
12.36
-5.43%
LH Labcorp Holdings Inc.
232.00
-0.99%
GH Guardant Health, Inc.
36.71
+0.31%